Retatrutide 50mg is being studied in adults with obesity or excess weight related to metabolic conditions such as type 2 diabetes
This matches official guidelines (for example, Hospiras package insert)
Key results: 15 mg dose: Average weight loss of 22.5 percent (approximately 52 pounds for a 230-pound individual) 10 mg dose: Average weight loss of 21.4 percent 5 mg dose: Average weight loss of 16.0 percent Over 85 percent of participants at 10 mg or 15 mg lost at least 10 percent of body weight Over 50 percent at 15 mg lost at least 20 percent SURMOUNT-5, a head-to-head trial comparing tirzepatide to semaglutide, confirmed tirzepatides superiority at matched doses
This starting dose is not therapeutically effective on its own it is a dose titration period to help the body adjust and reduce gastrointestinal side effects before escalating.
You can check with your insurance carrier or use Ro's GLP-1 Insurance Coverage Checker to see what your plan covers
Annual vaccination is recommended, especially for older adults, pregnant women, and those with underlying health conditions
